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The protein tyrosine phosphatase SHP-2 functions in
many diverse signalling pathways. The recent
identification of a SHP-2-binding protein as a
homologue of the Grb2-associated adaptor protein Gab1
sheds light on the role of SHP-2 in immune signalling.
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Immune signalling encompasses many diverse processes,
including responses to antigens and to cytokines such as
interleukins and interferons. These signalling pathways
are generally initiated by the activation of protein tyrosine
kinases and lead to the involvement of multiple intracell-
ular signalling cascades, including activation of the
Ras–mitogen-activated protein (MAP) kinase pathway and
activation of phosphatidylinositol 3-kinase (PI 3-kinase),
which itself couples to a range of signalling pathways. 
A common feature in intracellular signalling pathways is
the assembly of multi-protein complexes involving exten-
sive protein–protein interactions. These associations can
be directed by a number of protein interaction domains,
including Src homology 2 (SH2) domains, which bind
phosphotyrosine residues, and SH3 domains, which bind
proline-rich regions, amongst others. The recent charac-
terisation of a new adaptor protein — termed Grb-2-asso-
ciated binder 2 (Gab2) — that binds to the cytoplasmic
protein tyrosine phosphatase SHP-2 adds to the ever-
growing family of scaffolding or docking proteins that are
involved in immune signalling [1]. Other important
examples of these docking proteins include the cytosolic
Vav protein and the membrane-localised linker for acti-
vated T cells (LAT). These proteins serve not only as a
nucleation point for the regulated assembly of multi-
protein complexes but may also be involved in targeting
the entire complex to a particular subcellular location, for
example pleckstrin homology (PH) domains can target
proteins for membrane localisation.
An intriguing finding is that SHP-2 is often found in these
signalling complexes. This enzyme was cloned and identi-
fied only six years ago and has since been implicated in
many different signalling pathways, including those initi-
ated by stimulation with growth hormone or insulin, or by
triggering of the T-cell receptor or cytokine receptors [2].
SHP-2 and the related enzyme SHP-1 are unique amongst
tyrosine phosphatases as they have two tandem SH2
domains. Besides serving to target SHP-2 to various tyro-
sine-phosphorylated proteins, these SH2 domains also
regulate the activity of SHP-2. In the unbound state,
SHP-2 adopts a ‘closed’ conformation in which the amino-
terminal SH2 domain interacts extensively with the phos-
phatase domain, blocking the active site. Upon binding of
the SH2 domains to a tyrosine-phosphorylated target, the
enzyme adopts an ‘open’, active conformation [3]. Thus,
the SH2 domains not only direct SHP-2 to the correct
intracellular location but also repress the catalytic activity
until SHP-2 is localised to an appropriate protein complex.
SHP-2 is required for the activation of the Ras–MAP
kinase cascade, because the expression of a catalytically
inactive, dominant-interfering form of SHP-2 inhibits
MAP kinase activation in response to various signals [2].
SHP-2 function is also required for activation of
cytokine-induced immediate-early gene expression. The
precise point(s) at which SHP-2 acts in signalling path-
ways, however, is unclear. Several reports have placed
SHP-2 upstream of MAP kinase, and perhaps even
upstream of Ras. Studies in the fruit fly Drosophila
melanogaster suggest, however, that SHP-2 function is not
that simple. Corkscrew (Csw), the Drosophila homologue
of SHP-2, regulates the Sevenless signalling pathway,
which triggers differentiation of the R7 photoreceptor
cell in the compound eye. Genetic experiments have
revealed the complexity of SHP-2 action, showing that
Csw acts either parallel to or both upstream and down-
stream of Ras in the Sevenless pathway [4]. The docking
protein Dos (for daughter of Sevenless) is a binding
target and putative substrate for Csw and is required for
the signalling roles of Csw [5,6]. 
By analogy to the Drosophila Sevenless signalling pathway,
SHP-2 signalling in immune cells was predicted to involve
a Dos homologue. Indeed, a common feature in immune
signalling pathways is the association of SHP-2 with a tyro-
sine-phosphorylated cytosolic docking protein of
~95–110 kDa, which also forms a complex with various
other signalling proteins such as the adaptor proteins  Grb2
and Shc, and the p85 regulatory subunit of PI 3-kinase [7].
The recent purification and cloning of this ~95–110 kDa
docking protein [1] have in fact revealed that it has only
limited homology to Dos, restricted to the PH domain, but
greater similarity to Gab1, a mammalian adaptor protein
involved in diverse receptor signalling pathways, as shown
in Figure 1: for this reason, it has been christened Gab2.
The amino-acid identity outside the PH domain is only
30% between Gab1 and Gab2; the relative positions of
potential tyrosine phosphorylation sites, proline-rich
domains, and the c-Met-binding domain (a region in Gab1
that binds to the c-Met receptor) are conserved, however,
consistent with the proposed roles for these proteins as
assembly points for multi-protein complexes ([1]; Figure 1).
Initial studies of Gab2 in cytokine signalling, carried out
in BaF3 cells (interleukin-3 (IL-3)-dependent haemopoi-
etic cells), have provided some surprising insights into
the role of SHP-2. Gu et al. [1] mapped the binding sites
of the SH2 domains of SHP-2 to tyrosines 604 and 633 of
Gab2: truncating the carboxy-terminal residues from tyro-
sine 604 onwards (∆Y2 Gab2), or mutating tyrosines 604
and 633 to phenylalanine (Y2F Gab2), resulted in forms
of Gab2 that were unable to bind SHP-2. The associa-
tions of Gab2 with other signalling proteins, such as Shc,
Grb2, and p85, were unaffected by these alterations.
Expression of the ∆Y2 or Y2F versions of Gab2 inhibited
IL-3-induced immediate-early gene expression, showing
that SHP-2 association with Gab2 is required for the
mediation of these signals. MAP kinase activation is
unexpectedly potentiated in these experiments, however,
suggesting that SHP-2 is acting in a pathway either paral-
lel to or downstream of MAP kinase to regulate gene
expression. The potentiation of MAP kinase activity by
the ∆Y2 or Y2F forms of Gab2 could be explained by
stimulation of the Ras–MAP kinase pathway resulting
from PI 3-kinase activation, as the PI 3-kinase p85
subunit binding sites on Gab2 are unaffected by the
mutations (an interpretation consistent with some recent
studies of Gab1 — see [8]). Interestingly, expression of
dominant-negative SHP-2 inhibits both induction of
immediate-early gene expression and activation of MAP
kinase [1], demonstrating that SHP-2 acts in at least two
distinct places in the signalling pathways.
But where exactly does SHP-2 act in cytokine signalling?
Figure 2 illustrates some of the possibilities. The function
of SHP-2 in regulating gene expression clearly requires
Gab2 (Figure 2, arrow d). The role of SHP-2 in activating
MAP kinase, however, may or may not be Gab2 depen-
dent. Only about 10% of total cellular SHP-2 appears to be
associated with Gab2 in IL-2-stimulated BaF3 cells, and
other SHP-2-associated proteins have been observed, sug-
gesting that SHP-2 may act through a Gab2-independent
pathway to activate MAP kinase (Figure 2, arrow a) [1].
Alternatively, cytokine-induced MAP kinase activation
could be mediated by the dual actions of PI 3-kinase and
SHP-2 both acting through Gab2 (Figure 2, arrows b,c). In
this scenario, overexpression of mutated forms of Gab2
that do not bind SHP-2 could potentiate MAP kinase acti-
vation through increased PI 3-kinase activity, thereby
overcoming the loss of the SHP-2 contribution. Expres-
sion of a mutated form of Gab2 in which the binding sites
for both SHP-2 and p85 were abolished would address this
question: if the regulation of MAP kinase by SHP-2 were
Gab2 independent, then expression of dominant-negative
SHP-2 in combination with the form of Gab2 lacking the
binding sites for both SHP-2 and p85 would be predicted
to inhibit MAP kinase activation.
Although the identification of Gab2 has clarified the role
of SHP-2 in immune signalling, many questions remain
unanswered. In particular, the substrate(s) for SHP-2 has
yet to be identified. Gab2/Dos has been proposed as a
substrate because of its association with ‘substrate-trap-
ping’ mutants (catalytically inactive mutants that still
bind substrates) of SHP-2/Csw [5,9] and because of its
dephosphorylation by SHP-2 following stimulation of
BaF3 cells [9,10]. Overexpression of catalytically inactive
SHP-2 results in the hyperphosphorylation of Gab2, con-
sistent with Gab2 being a SHP-2 substrate [9]. Mutating
the SHP-2-binding sites of Gab2 does not result in
increased IL-3-stimulated Gab2 phosphorylation [1],
however, as one might expect if Gab2 were a SHP-2 sub-
strate because, in this context, SHP-2 would not be
recruited to Gab2, a step that might also be necessary for
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Figure 1
Alignment of Gab2 with Dos and Gab1. The
PH domains are shown in blue, the c-Met-
binding domains in green and the proline-rich
regions in purple. The percentage amino-acid
identity between the PH domains and the
carboxy-terminal portions of the proteins is
indicated. The circled red Ys mark tyrosine
residues that are known or potential binding
sites for the SH2 domains of SHP-2/Csw
(consensus sequence (V/L)XYXX(V/L) in
single-letter amino-acid code); the circled
black Ys mark tyrosine residues that are
binding sites for PI 3-kinase (consensus
sequence YXXM).
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SHP-2 activation. A problem in interpreting this experi-
ment, however, is that the loss of the two phosphorylation
sites in Gab2 that are required for SHP-2 binding might
mask increased phosphorylation at other sites. Interest-
ingly, we found that expression of catalytically inactive
SHP-2 in activated T cells results in the hyperphosphory-
lation of three proteins: Gab2, LAT and an unidentified
p52 protein, all potential targets for SHP-2 [11]. These
hyperphosphorylation events were only observed in the
membrane fraction, so the subcellular localisation of mul-
timeric complexes is clearly critical.
How is the subcellular targeting of Gab2 regulated? The
presence of a PH domain in Gab2 suggests that this
adaptor protein is targeted to the membrane; indeed, after
IL-3 stimulation of BaF3 cells, a small amount of Gab2
was found associated with SHP-2 and PI 3-kinase in the
membrane fraction [10]. Similarly, in Jurkat T cells a
small amount of a Gab2–SHP-2 complex was found at the
membrane after stimulation; expression of catalytically
inactive SHP-2 significantly increased membrane target-
ing [11]. If the membrane-localised LAT protein is a
target for SHP-2 activity, then this increase in membrane
targeting could be explained by binding of SHP-2 to LAT
via the inactive catalytic domain of SHP-2. Alternatively,
LAT may play a direct role in targeting the Gab2–SHP-2
complex to the membrane.
How SHP-2 is involved in coupling signals to the MAP
kinase pathway and to regulation of immediate-early
gene expression is still unclear. As SHP-2 has a positive
effect on coupling of receptors to MAP kinase, its key
substrate(s) is presumably a negative regulator of this
pathway. As indicated above, experiments need to be
carried out to determine whether MAP kinase regulation
by SHP-2 is dependent or independent of Gab2. Several
other SHP-2-binding proteins have been identified,
including the SHPS-1/SIRP family of inhibitory receptor
proteins and a 135 kDa SHP-2-associated protein [9] that
may be involved in the Gab2-independent actions of
SHP-2. Regulation of immediate-early gene expression
by the Gab2–SHP-2 complex may occur at a point down-
stream of MAP kinase activation, or alternatively via a
parallel pathway (Figure 2, arrow d). The cloning of
Gab2 adds to the numerous ports of call identified for
SHP-2; now the challenge lies in mapping the course
that SHP-2 navigates through the many different intra-
cellular signalling cascades.
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Figure 2
Involvement of SHP-2 in IL-3 signalling. Binding of IL-3 to its receptor
leads to activation of Janus kinases (JAK) and tyrosine phosphorylation
of the adaptor protein Gab2. The signalling pathways downstream of
Gab2 are identified by four arrows (a–d); see text for details. Each
pathway ultimately leads to expression of immediate-early genes, for
example c-fos. Binding sites on Gab2 are marked as Y* for
phosphotyrosine and PXXP for proline-rich regions. Note that the
motifs for association of proteins with Gab2 have been experimentally
defined only for SHP-2. Besides associating with Gab2, SHP-2 may
also associate with an unknown adaptor protein marked as ?.
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